You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 845 ABL503 (TJ-L14B), PD-L1×4–1BB bispecific antibody, reinvigorates exhausted tumor-infiltrating CD8+ T cells and synergizes with PD-1 blockade

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Combination Immunotherapies
845 ABL503 (TJ-L14B), PD-L1×4–1BB bispecific antibody, reinvigorates exhausted tumor-infiltrating CD8+ T cells and synergizes with PD-1 blockade

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023126012
Dec 20235007
Jan 20243901
Feb 20243804
Mar 20244809
Apr 202454015
May 202456016
Jun 20242203
Jul 20249605
Aug 20241603
Sep 20243004
Oct 20242809
Nov 202434011
Dec 202448012
Jan 202548011
Feb 2025208
Mar 20250011
Apr 2025107
May 2025005
Jun 2025006
Total7360159